4//SEC Filing
Milligan John C.K. IV 4
Accession 0001387131-21-003348
CIK 0000025743other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 9:06 PM ET
Size
11.9 KB
Accession
0001387131-21-003348
Insider Transaction Report
Form 4
Milligan John C.K. IV
DirectorPresident, Secretary, Director10% Owner
Transactions
- Exercise of In-Money
Warrant (right to buy)
2021-03-04−179,000→ 0 totalExercise: $0.24Exp: 2021-03-06→ Common Stock (179,000 underlying) - Tax Payment
Common Stock
2021-03-04$1.46/sh−29,964$43,747→ 1,693,455 total - Exercise of In-Money
Common Stock
2021-03-04$0.24/sh+179,000$43,748→ 1,723,419 total - Gift
Common Stock
2020-06-05−434,814→ 0 total(indirect: See Footnote)
Holdings
- 3,582,373(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]On March 4, 2021, the reporting person exercised a warrant to purchase 179,000 shares of issuer common stock for $0.2444 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 29,964 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 149,036 shares.
- [F2]Shares were owned by the Milligan Irrevocable Nonexempt Trust - 2014. These securities were held in a trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
- [F4]The warrant vested quarterly in eight equal installments commencing June 30, 2011, becoming fully-vested on March 31, 2013.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001532230
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 9:06 PM ET
- Size
- 11.9 KB